You are here

Home » Content

HEMODİYALİZ HASTALARINDA TOTAL LENFOSİT, CD4, CD8 VE CD4/CD8 ORANINA DEĞİŞİK FAKTÖRLERİN ETKİLERİ

THE EFFECTS OF VARIOUS FACTORS ON TOTAL LYMPHOCYTE, CD4, CD8 LYMPHOCYTE AND CD4/CD8 RATIO IN HEMODIALYSIS PATIENTS

Journal Name:

  • Türk Nefroloji, Diyaliz ve Transplantasyon Dergisi

Publication Year:

  • 1995

Key Words:

Keywords (Original Language):

Author NameUniversity of AuthorFaculty of Author
Abstract (2. Language): 
is shown that rHu-EPO and calcitriol treatment and type of dialysis membrane effect total lymphocyte CD4, CD8 lymphocyte counts and CD4.CD8 ratio in hemodialysis patients (HP). The aim of this study was investigate the effect of different factors on these cell populations in hemodialysis patients. 10 healthy indi¬viduals and 36 HP were included in this study. Pati¬ents were dialysed 4 hours twice or three times weekly with polysulphone membrane. All patients were given calcitriol (0.25 microgram! day), calcium (2 gram/day) and other medications as required. Blood samples were taken before each dialysis session. Total lymphocytes count was performed using Technicon HI 873. CD4, CD8 lymphocytes was meusared by IF A. Data were analysed by minitab computer statis¬tic programs (t test, correlation tests). Total lymphocytes, CD4, CD8 lymphocytes and CD4, CD8 lymphocytes and CD4: CD8 ratio of IIP were those of the control group. There was no correlation between total lymphocytes, CD4, CD8 lymphocytes, CD4.CD8 ratio and age, sex, use of rHu-EPO, weight, liver function, time on dialysis and DIIEA-S in HP. Total lymphocytes, CD4, CD8 lymphocytes and CD4.CD8 ratios were high in HP with serum creatinine levels lower than 7 mg/dl. Although this increase was not significant. Increase in CD8 and decrease in CD4.CD8 ratio were significant in anti HCVpositive HP. Key
Bookmark/Search this post with
Abstract (Original Language): 
Total lenfosit, CD4, CD8 lenfosit, CD4.CD8 oranını, hemodiyaliz hastalarında diyaliz membranı tipi, eritropoieün ve kalsitriol kullanımının etkilediği bildirilmektedir. Bu araştırmada 10 sağlıklı gönüllü ve 36 hemodiyaliz hastası dahil edildi. Hastalar haftada 2 veya 3 kez 4 saat süre ile polisulfon membranlı diyalize giriyorlardı. Tüm hastalara 0.25 \xglgün kalsit-riol, 2 g/gün kalsiyum ve diğer rutin kronik böbrek yetmezliği ilaçları veriliyordu. Kan örnekleri diyaliz öncesi alındı. Total lenfosit sayımı Technicon Hl 873 ile yapıldı. CD4 ve CD8 immunfluoresan tekniği ile sayıldı. Sonuçlar AppsIMinitab bilgisayar istatistik programı ile değerlendirildi. Hemodiyaliz hastaların¬da total lenfosit, CD4, CD8 ve CD4:CD8 oranı kont¬rol grubuna göre daha düşüktü (p<0.01). Total lenfosit, CD4, CD8 ve CD4.CD8 oranı ile yaş, cinsiyet, eritropoieün kullanımı, ağırlık, karaciğer fonksiyon testleri, diyaliz süresi, kortizol, total testosteron ve DHEA-S arasında anlamlı korelasyon yoktu. Anti-HCV pozitif hastalarda anti-HCV negatif hastalara göre istatistiki olarak CD8 yüksek, CD4:CD8 oranı ise düşüktü (p<0.01).
FULL TEXT (PDF): 
PDF icon pdf_tndt_99.pdf
  • 3
146-150
  • Turkish

REFERENCES

References: 

1. Laurence J. T-Cell subsets in health, infectious disease, and idiopathic CD4 T lymphocytopenia. Ann Intern Med 1993;119:55-62.
2. Standland BE, Winkel P. Physiological variability ofleu-cocytes in healthy subjects. In: Koepke JA, ed. Differen¬tial Leucocyte Counting. Skokie. Illinois: Colloge of American Pathology 1978; 66: 159-162.
3. Ban M. The Kidney. In: Hemopoietic system. WB Sa-
unders Company, Philadelphia 1991, pp: 2244-2251.
4. Raska K, Raskova J, Shea SM, Frankel RM. T cell
subsets and cellular immunity in end-stage renal disease. Am J Med 1983; 75 (5): 734-740.
149
5. Baldev TL, Vazelou E, Naumova E, Ivanova R. Immunological investigation on hemodialysis patients treated with human erythropoietin. XXVIIth Congress of Euro¬pean Dialysis and Transplant. Ossociation European Re¬nal Association. September 5-8, 1990; Vienna, Austria, 236.
6. Robles NR, Dobiare E, Esparage FS. EPO effects on lympcytic subpopulations and hemodialysis induced leu-kopenia. XXVIIth Congres of European Dialysis and Transplant. Association European Renal Association. September 5-8, 1990; Vienna, Austria, 256.
7. Nordio M, Ortoloni C, De Cecco Guarda G. T-lymphoc-tes behaviour in cuprophan vs. polyacrylonytrile dialy¬sis. XXVIIth Congres of European Dialysis and Trans¬plant. Association European Renal Association. Septem¬ber 5-8,1990; Vienna, Austria, 154.
8. Angleni D, Carimi A, Guisti R, Mazotta L, Antonelli A.
T-cell imminity variations after D3 I.V. in uremic pati¬ents secondary hyperparathroidizm. XXVIIth Congres of European Dialysis and Transplant. Association Europe¬an Renal Association. September 15-18, 1993; Glaskow
Scotland, 119.
9. Tollerud DJ, Clark JW, Brown LM, Neuland CY, Trost
LK. The influence of age, race and gender peripheral blood mononuclear cell subsets in healthy. J Clin Immu¬nol 1989; 9 (3): 214-222.
10. Tollerud DJ, Ilstad ST, Brown LM, Clark JW, Blattner
W A. T cell subsets in heamthy teenagers: Transition to the adult phenotypeb Clin Immunol Immunopathol 1990; 56 (1): 88-96.
11. Levi FA, Canon C, Sulon J, Ponsart ED. Circaidian rhytms in circulating T lymphocytes subtypes and plas¬ma testosterone, total and free Cortisol in five healthy men. Clin Exp Immunol 1988; 71 (2): 329-335.
12. Negel JE, Chrest FJ, Pyle RS, Adler WH. Monoclonal
antibody analysis of T lymphocyte subsets in young and aged adults. Immunol Commun 1983; 12 (2): 223-237.
13. Reichert T, De Bruyere M, Deneys V, Linden J. Lymphocyte subsets reference ranges in adult Caucasi¬ans. Clin Immunol Immunopathol 1991; 60 (2): 190¬208.
14. Fernandez A, Molero T, Mataix R, Perdomo M, Veqa N. Lymphocte subsets in bone marrow and blood samples in patients with rHu-EPO. XXVIIth Congres of Europe¬an Dialysis and Transplant. Association European Renal Association. September 15-18, 1993; Glaskow-Scotland, 244.
15. Mitwalli A, Mohaya SL, Wakeel JE, Rotimi V, Zaben
AL. Hepatitis C in chronic renal failure patients. J Neph-rol 1992; 12: 288-291.
16. Fiunstone SM, Kapikan AZ, Purchel RH. Transfusion associated hepatitis not due to hepatitis A or B. N Engl J
Med 1975; 292: 767-770.
17. Sprent J, Webb SR. Function and specifity of T cell sub¬sets in the mouse. Adv Immunol 1987; 41: 39-133.
18. Thomas HC, Brown D, Routhier G, Kung PC, Sherlpck S. Inducer and suppressor T cells in hepatitis B virus in¬duced liver disease. Hepatology 1982; 2 (2): 202-204.
19. Urina P, Herbelin A, Zingraf J. Permeability of celulosic and non-celulosic membranes to endotoksin subunits and cytokine production during in vitrohemodialysis.
Nephron Dial Transplant 1992; 7 (1): 16-28.
20. Tetta C, Fidello T, Licata C. Prodiction of TNF-alpha in patients on hemodiaphiltration. Nephron 1992; 61 (2): 135-138.
21. Ryan J, Beyon H, Rees AJ. Evaluation of in vitro pro¬duction of TNF by monocytes in hemodialysis patients.
Blood Purif 1991; 3 (3): 142-147.

Thank you for copying data from http://www.arastirmax.com